Cargando…
Correction: Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329067/ https://www.ncbi.nlm.nih.gov/pubmed/34112951 http://dx.doi.org/10.1038/s41416-021-01447-1 |
| _version_ | 1783732422598197248 |
|---|---|
| author | Guenther, Michael Haas, Michael Heinemann, Volker Kruger, Stephan Westphalen, Christoph Benedikt von Bergwelt-Baildon, Michael Mayerle, Julia Werner, Jens Kirchner, Thomas Boeck, Stefan Ormanns, Steffen |
| author_facet | Guenther, Michael Haas, Michael Heinemann, Volker Kruger, Stephan Westphalen, Christoph Benedikt von Bergwelt-Baildon, Michael Mayerle, Julia Werner, Jens Kirchner, Thomas Boeck, Stefan Ormanns, Steffen |
| author_sort | Guenther, Michael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8329067 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83290672021-08-19 Correction: Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study Guenther, Michael Haas, Michael Heinemann, Volker Kruger, Stephan Westphalen, Christoph Benedikt von Bergwelt-Baildon, Michael Mayerle, Julia Werner, Jens Kirchner, Thomas Boeck, Stefan Ormanns, Steffen Br J Cancer Correction Nature Publishing Group UK 2021-06-10 2021-08-03 /pmc/articles/PMC8329067/ /pubmed/34112951 http://dx.doi.org/10.1038/s41416-021-01447-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Guenther, Michael Haas, Michael Heinemann, Volker Kruger, Stephan Westphalen, Christoph Benedikt von Bergwelt-Baildon, Michael Mayerle, Julia Werner, Jens Kirchner, Thomas Boeck, Stefan Ormanns, Steffen Correction: Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study |
| title | Correction: Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study |
| title_full | Correction: Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study |
| title_fullStr | Correction: Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study |
| title_full_unstemmed | Correction: Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study |
| title_short | Correction: Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study |
| title_sort | correction: bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the aio-pk0104 phase 3 study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329067/ https://www.ncbi.nlm.nih.gov/pubmed/34112951 http://dx.doi.org/10.1038/s41416-021-01447-1 |
| work_keys_str_mv | AT guenthermichael correctionbacteriallipopolysaccharideasnegativepredictorofgemcitabineefficacyinadvancedpancreaticcancertranslationalresultsfromtheaiopk0104phase3study AT haasmichael correctionbacteriallipopolysaccharideasnegativepredictorofgemcitabineefficacyinadvancedpancreaticcancertranslationalresultsfromtheaiopk0104phase3study AT heinemannvolker correctionbacteriallipopolysaccharideasnegativepredictorofgemcitabineefficacyinadvancedpancreaticcancertranslationalresultsfromtheaiopk0104phase3study AT krugerstephan correctionbacteriallipopolysaccharideasnegativepredictorofgemcitabineefficacyinadvancedpancreaticcancertranslationalresultsfromtheaiopk0104phase3study AT westphalenchristophbenedikt correctionbacteriallipopolysaccharideasnegativepredictorofgemcitabineefficacyinadvancedpancreaticcancertranslationalresultsfromtheaiopk0104phase3study AT vonbergweltbaildonmichael correctionbacteriallipopolysaccharideasnegativepredictorofgemcitabineefficacyinadvancedpancreaticcancertranslationalresultsfromtheaiopk0104phase3study AT mayerlejulia correctionbacteriallipopolysaccharideasnegativepredictorofgemcitabineefficacyinadvancedpancreaticcancertranslationalresultsfromtheaiopk0104phase3study AT wernerjens correctionbacteriallipopolysaccharideasnegativepredictorofgemcitabineefficacyinadvancedpancreaticcancertranslationalresultsfromtheaiopk0104phase3study AT kirchnerthomas correctionbacteriallipopolysaccharideasnegativepredictorofgemcitabineefficacyinadvancedpancreaticcancertranslationalresultsfromtheaiopk0104phase3study AT boeckstefan correctionbacteriallipopolysaccharideasnegativepredictorofgemcitabineefficacyinadvancedpancreaticcancertranslationalresultsfromtheaiopk0104phase3study AT ormannssteffen correctionbacteriallipopolysaccharideasnegativepredictorofgemcitabineefficacyinadvancedpancreaticcancertranslationalresultsfromtheaiopk0104phase3study |